NVIDIA Invests in AI Inference Startup Baseten, Raising $2 Billion in New Funding
Gold财经 reports, according to Bloomberg, AI inference platform Baseten, backed by NVIDIA, is negotiating a new funding round of $2 billion, to be conducted in two tranches with valuations of $26 billion and up to $30 billion respectively. The company was valued at $13 billion during its June funding round; the upper limit of this round represents nearly a 2.3x increase. The current round is led by existing investor Sands Capital.
Baseten specializes in large model deployment and online inference services, serving clients such as Notion and Cursor, with the platform handling over one billion inference requests daily. This round of funding reflects a shift in capital focus from AI training to inference infrastructure.
NVIDIA Invests in AI Inference Startup Baseten, Aiming for $2 Billion in New Funding
JinseShare
Summary
NVIDIA-backed AI inference startup Baseten is in discussions for a new $2 billion funding round, with a potential valuation of up to $300 billion. The company, valued at $130 billion in June, is being led by Sands Capital in this new funding round. Baseten provides large model deployment and online inference services to clients such as Notion and Cursor, handling over one billion daily requests. New token listings remain a key focus for investors monitoring AI infrastructure growth.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.